Biopharma Specialization Training 
European Pharmaceutical Review
JUNE 8, 2023
A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.
Pharmaceutical Technology
FEBRUARY 28, 2023
Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.
Pharmaceutical Technology
MARCH 22, 2023
The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Chromatography and clarification play vital parts in biopharma manufacturing, yet there is room for improvement in processes to eliminate inefficiencies and increase yield.
Pharmaceutical Technology
JANUARY 20, 2023
Nevertheless, the potential for mAb therapies in treating medical conditions that have limited options means that biopharma companies are investing considerable resources in development. The post Overcoming challenges with scalability in biopharma manufacturing appeared first on Pharmaceutical Technology. Download to learn more.
PM360
JUNE 30, 2022
The unit will specialize in medical communications, medical affairs, real-world evidence, and outcomes research. It includes agency groups ApotheCom, Ashfield MedComms, and Nucleus Group as well as specialized medical services companies MediStrava and MedEvoke.
European Pharmaceutical Review
FEBRUARY 21, 2023
Hiring a good team is paramount – as is training and development. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? We are already seeing rapid growth in the UK ‘specials’ market for a variety of conditions, with some very positive patient outcomes.
Expert insights. Personalized for you.
98 
Let's personalize your content